Please assess the completion status of the following clinical trial:

Trial Title: Role of Dutasteride in Treatment of Chronic Prostatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients aged between 40 and 70 years old, diagnosed with chronic prostatitis based on the presence of pelvic pain for ≥3 months of the preceding 6 months~Exclusion Criteria:~Patients with bacterial prostatitis~* documented site of infection along the urinary tract,~* urinary bladder tumors~* prostate cancer~* previous history of pelvic radiation or chemotherapy were excluded from our study.

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Dutasteride (Type: ACTIVE_COMPARATOR): Dutasteride of 0.5 mg once daily was given for 3 months compared to a placebo.
- Placebo (Type: PLACEBO_COMPARATOR): same form and color of Dutasteride tablet was given at the same regimen to act as a placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).